[9,10] Further, up to 10% of myelolipoma patients have been reported to have CAH.[11] The possible mechanism underlying this association is based on the exposure to a chronically excessive level of ACTH leading to the development of adrenal myelolipoma.[3,9,10] This is supported by the fact that many myelolipoma patients with CAH are untreated or have poorly controlled CAH. This evidence concerns the gene POMC and adrenal gland myelolipoma.